ALFA Finder| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 37.8 | 35.0 | 50.6 |
| Other income | 0.9 | 0.8 | 2.8 |
| Total income | 38.6 | 35.8 | 53.3 |
| Profit before exceptional items & tax | -1.1 | 0.1 | -8.3 |
| Profit before tax | -1.1 | 0.1 | -8.3 |
| Net profit | 1.0 | 0.1 | -8.5 |
| Operating margin | -2.8% | 0.3% | -15.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | +900.00% |
|---|---|
| Revenue, year on year | -25.30% |
| Operating profit, year on year | +82.00% |
| Operating profit, quarter on quarter | -185.70% |
BSE results filing, NSE: INDRANIB. Figures extracted from the filing.
Indrayani Biotech Ltd: key numbers
- Share price
- ₹8.56
- Market cap
- ₹45.94 Cr
- Revenue (annual)
- ₹137.8 Cr
- Net profit (annual)
- ₹2.16 Cr
- P/E (TTM)
- 21.9×Sector 25.4×
- Promoter holding
- 32.89%-0.03% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indrayani Biotech Ltd
All →Indrayani Biotech Other Announcement
Indrayani Biotech filed its quarterly shareholding pattern for 30 September 2026. Promoter group holds 32.89% of equity; this is routine compliance with no corporate event.
Indrayani Biotech Annual Report
Indrayani Biotech has filed its 34th Annual Report for FY2025-26, containing the AGM notice for 30 November 2026 by VC/OAVM. The chairman notes a Rights Issue was initiated in October 2026 to raise capital.
Indrayani Biotech Annual General Meeting
Indrayani Biotech's 34th AGM is set for 30 November 2026, with book closure from 24 to 30 November. Remote e-voting runs 27 to 29 November 2026.
Indrayani Biotech Management Change
Indrayani Biotech appointed Ms. N.S. Poornima as Secretarial Auditor and accepted the resignation of Company Secretary C.S. Shanmuga Sundar effective 2 Nov 2026. The KMP departure due to personal health is the material change.
Indrayani Biotech Capital Structure Change
Indrayani Biotech allotted 83,64,036 rights equity shares at Rs 15 (75,03,333 fully paid) and Rs 3.75 (8,60,703 partly paid). Issue receipts total about Rs 11.58 Crore.
- Value
- ₹11.58 Cr
Indrayani Biotech Capital Structure Change
Indrayani Biotech's committee allotted 83,64,036 partly paid rights shares at Rs.15 each, worth about Rs.12.55 crore. Application money of Rs.3.75 per share has been received.
- Value
- ₹12.55 Cr